用血清生物标志物评估肠道透性,以早期了解花生过敏试验
Ozge Nur Aktas1,2, Allyson Mateja3, Min Jenny Li1
1Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland, USA.
Allergy
|January 13, 2025
概括
在食物过敏 (FA) 和对照的婴儿中,肠道透性 (IP) 类似. 早期引入花生并没有改变敏感儿童的IP,这表明IP不是FA发展的关键因素.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 儿科 儿科 儿科
背景情况:
- 肠道屏障功能障碍与食物过敏 (FA) 的发展有关.
- 在IgE介导的FA中,关于肠道透性的证据是相互矛盾的.
- 在患有湿疹和FA的婴儿中调查IP至关重要.
研究的目的:
- 为了确定IP是否在患有FA的湿疹儿童与对照儿童之间有所不同.
- 评估花生敏感化,过敏和早期引入对IP的影响.
- 使用血清生物标志物 (素,可溶性CD14,肠脂肪酸结合蛋白) 进行IP评估.
主要方法:
- 血清肠道透性标记物 (sIPM) 通过ELISA测量在FA受试者和亚托皮对照 (AC) 中.
- 参与者来自早期学习关于花生过敏的试验.
- 分析涉及参数测试和线性回归模型,将sIPM与临床特征相关联.
主要成果:
- 在FA受试者和AC在基线或60个月之间没有发现sIPM水平的显著差异.
- 发病时的年龄,湿疹的严重程度,花生敏感性/过敏性和早期引入花生与sIPM水平没有相关性.
- 总IgE,乙素,花生特异性IgE,IgG4和IgG4/IgE比率也与sIPM水平没有相关性.
结论:
- 与对照人群相比,在患有FA的婴儿中没有检测到改变肠道透性 (IP).
- 早期引入花生对花生敏感儿童的IP没有影响.
- 血清生物标志物不支持改变的IP在这个队列中FA的发展中的作用.
相关概念视频
Serum Laboratory Studies, Stool Test, Breath Test
1.2K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K
Bioavailability Enhancement: Drug Permeability Enhancement
314
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
314


